Sanofi (SNY) to Acquire Stock of Regeneron (REGN); Will Have $500M+ Stake
- S&P 500, Nasdaq dip as interest rate concerns, earnings weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- United Airlines maintains forecast after Q1 results top Wall Street estimates
- US dollar weakens as market consolidates gains, but uptrend intact
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- Barnes & Noble Education (BNED) Enters Definitive Agreement with Immersion (IMMR)
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
Regeneron Pharmaceuticals (REGN) resume trading up nearly 7% following Sanofi news
February 11, 2013 10:07 AM ESTRegeneron Pharmaceuticals (NASDAQ: REGN) resume trading up nearly 7% following Sanofi news.... More
Regeneron Pharmaceuticals (REGN) set to resume trading at 10:05AM after Sanofi News
February 11, 2013 9:47 AM ESTRegeneron Pharmaceuticals (NASDAQ: REGN) will resume trading at 10:05AM ET following news Sanofi (NYSE: SNY) intends to acquire Common Stock of Regeneron through open market purchases and direct purchases from shareholders.... More
Regeneron Pharmaceuticals, Inc. (REGN) trading halted with news pending
February 11, 2013 9:20 AM ESTRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) trading halted with news pending.... More